Literature DB >> 18823944

Inhibition of transcriptional activity of c-JUN by SIRT1.

Zhanguo Gao1, Jianping Ye.   

Abstract

c-JUN is a major component of heterodimer transcription factor AP-1 (Activator Protein-1) that activates gene transcription in cell proliferation, inflammation and stress responses. SIRT1 (Sirtuin 1) is a histone deacetylase that controls gene transcription through modification of chromatin structure. However, it is not clear if SIRT1 regulates c-JUN activity in the control of gene transcription. Here, we show that SIRT1 associated with c-JUN in co-immunoprecipitation of whole cell lysate, and inhibited the transcriptional activity of c-JUN in the mammalian two hybridization system. SIRT1 was found in the AP-1 response element in the matrix metalloproteinase-9 (MMP9) promoter DNA leading to inhibition of histone 3 acetylation as shown in a ChIP assay. The SIRT1 signal was reduced by the AP-1 activator PMA, and induced by the SIRT1 activator Resveratrol in the promoter DNA. SIRT1-mediaetd inhibition of AP-1 was demonstrated in the MMP9 gene expression at the gene promoter, mRNA and protein levels. In mouse embryonic fibroblast (MEF) with SIRT1 deficiency (SIRT1(-/-)), mRNA and protein of MMP9 were increased in the basal condition, and the inhibitory activity of Resveratrol was significantly attenuated. Glucose-induced MMP9 expression was also inhibited by SIRT1 in response to Resveratrol. These data consistently suggest that SIRT1 directly inhibits the transcriptional activity of AP-1 by targeting c-JUN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823944      PMCID: PMC2629791          DOI: 10.1016/j.bbrc.2008.09.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.

Authors:  D L Crowe; T N Brown
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.

Authors:  Muzahir H Tayebjee; H Sern Lim; Robert J MacFadyen; Gregory Y H Lip
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

3.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

4.  Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction.

Authors:  Ju-Hyung Woo; Jun Hee Lim; Young-Ho Kim; Seong-Il Suh; Do Sik Min; Jong-Soo Chang; Young Han Lee; Jong-Wook Park; Taeg Kyu Kwon
Journal:  Oncogene       Date:  2004-03-11       Impact factor: 9.867

5.  Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells.

Authors:  Swatee Dey; Vasudevan Bakthavatchalu; Michael T Tseng; Peng Wu; Rebecca L Florence; Eric A Grulke; Robert A Yokel; Sanjit Kumar Dhar; Hsin-Sheng Yang; Yumin Chen; Daret K St Clair
Journal:  Carcinogenesis       Date:  2008-08-01       Impact factor: 4.944

6.  Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta.

Authors:  Zhonglin Xie; Mahipal Singh; Krishna Singh
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

7.  Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.

Authors:  Hwei-Ling Cheng; Raul Mostoslavsky; Shin'ichi Saito; John P Manis; Yansong Gu; Parin Patel; Roderick Bronson; Ettore Appella; Frederick W Alt; Katrin F Chua
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

8.  Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

Authors:  Zhanguo Gao; Daniel Hwang; Fredly Bataille; Michael Lefevre; David York; Michael J Quon; Jianping Ye
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

9.  Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations.

Authors:  Ahmad Aljada; Husam Ghanim; Priya Mohanty; Tufail Syed; Arindam Bandyopadhyay; Paresh Dandona
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045

10.  Influence of aging and calorie restriction on MAPKs activity in rat kidney.

Authors:  Hyon Jeen Kim; Kyung Jin Jung; Byung Pal Yu; Chong Gun Cho; Hae Young Chung
Journal:  Exp Gerontol       Date:  2002 Aug-Sep       Impact factor: 4.032

View more
  44 in total

Review 1.  Regulation of SIRT1 in cellular functions: role of polyphenols.

Authors:  Sangwoon Chung; Hongwei Yao; Samuel Caito; Jae-Woong Hwang; Gnanapragasam Arunachalam; Irfan Rahman
Journal:  Arch Biochem Biophys       Date:  2010-05-05       Impact factor: 4.013

2.  SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress.

Authors:  Michael W McBurney; Katherine V Clark-Knowles; Annabelle Z Caron; Douglas A Gray
Journal:  Genes Cancer       Date:  2013-03

3.  Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice.

Authors:  Fen Xu; David Burk; Zhanguo Gao; Jun Yin; Xia Zhang; Jianping Weng; Jianping Ye
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

4.  Sirtuin 1 is a negative regulator of parathyroid hormone stimulation of matrix metalloproteinase 13 expression in osteoblastic cells: role of sirtuin 1 in the action of PTH on osteoblasts.

Authors:  Yurong Fei; Emi Shimizu; Michael W McBurney; Nicola C Partridge
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

5.  Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.

Authors:  Vamshi K Nimmagadda; Christopher T Bever; Narasimha R Vattikunta; Saifi Talat; Vakas Ahmad; Naveen K Nagalla; David Trisler; Susan I V Judge; Walter Royal; Krish Chandrasekaran; James W Russell; Tapas K Makar
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

6.  The Roles of SIRT1 in Cancer.

Authors:  Zhenghong Lin; Deyu Fang
Journal:  Genes Cancer       Date:  2013-03

7.  A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex.

Authors:  Sean M Armour; Eric J Bennett; Craig R Braun; Xiao-Yong Zhang; Steven B McMahon; Steven P Gygi; J Wade Harper; David A Sinclair
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

8.  Association of Serum Levels of Silent Information Regulator 1 with Persistent Organ Failure in Acute Pancreatitis.

Authors:  Jie Chen; Jianhua Wan; Wenqing Shu; Xiaoyu Yang; Liang Xia
Journal:  Dig Dis Sci       Date:  2019-05-04       Impact factor: 3.199

9.  Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.

Authors:  M Sulaiman; M J Matta; N R Sunderesan; M P Gupta; M Periasamy; M Gupta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

10.  Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines.

Authors:  Zheng Shen; Joanne M Ajmo; Christopher Q Rogers; Xiaomei Liang; Lisa Le; Michel M Murr; Yanhua Peng; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.